Dexamethasone sodium phosphate
IEDAT-04-2022
Phase 3 small_molecule completed
Quick answer
Dexamethasone sodium phosphate for Ataxia Telangiectasia is a Phase 3 program (small_molecule) at Quince Therapeutics with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Quince Therapeutics
- Indication
- Ataxia Telangiectasia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed